OCLI-023, a Novel Pyrimidine Compound, Suppresses Osteoclastogenesis In Vitro and Alveolar Bone Resorption In Vivo

• Hye Jung Ihn ,

  Contributed equally to this work with: Hye Jung Ihn, Taeho Lee

  Affiliation Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Taeho Lee ,

  Contributed equally to this work with: Hye Jung Ihn, Taeho Lee

  Affiliation College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Ju Ang Kim,

  Affiliation Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Doohyun Lee,

  Affiliation College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Nam Doo Kim,

  Affiliation New Drug Development Center, Daegu-Gyeongbuk Medical Innovation Foundation, Daegu, Republic of Korea

  ⨯
• Hong-In Shin,

  Affiliation Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Yong Chul Bae,

  Affiliation Department of Oral Anatomy and Neuroscience, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea

  ⨯
• Eui Kyun Park

  * E-mail: epark@knu.ac.kr

  Affiliation Department of Oral Pathology and Regenerative Medicine, School of Dentistry, IHBR, Kyungpook National University, Daegu, Republic of Korea

  ⨯